Abstract
Glycosphingolipids (GSLs) are a group of plasma-membrane lipids notable for their extremely diverse glycan head groups. The metabolic pathways for GSLs, including the identity of the biosynthetic enzymes needed for synthesis of their glycans, are now well understood. Many of their cellular functions, which include plasma-membrane organization, regulation of cell signaling, endocytosis, and serving as binding sites for pathogens and endogenous receptors, have also been established. However, an understanding of their functions in vivo had been lagging. Studies employing genetic manipulations of the GSL synthesis pathways in mice have been used to systematically reduce the large numbers and complexity of GSL glycan structures, allowing the in vivo functions of GSLs to be revealed from analysis of the resulting phenotypes. Findings from these studies have produced a clearer picture of the role of GSLs in mammalian physiology, which is the topic of this review.
Similar content being viewed by others
References
Merrill Jr., A.H.: Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem Rev 111(10), 6387–6422 (2011). doi:10.1021/cr2002917
Kolter, T., Proia, R.L., Sandhoff, K.: Combinatorial ganglioside biosynthesis. J Biol Chem 277(29), 25859–25862 (2002). doi:10.1074/jbc.R200001200
Cantu, L., Del Favero, E., Sonnino, S., Prinetti, A.: Gangliosides and the multiscale modulation of membrane structure. Chem Phys Lipids 164(8), 796–810 (2011). doi:10.1016/j.chemphyslip.2011.09.005
D’Angelo, G., Capasso, S., Sticco, L., Russo, D.: Glycosphingolipids: synthesis and functions. FEBS J 280(24), 6338–6353 (2013). doi:10.1111/febs.12559
Yu, R.K., Tsai, Y.T., Ariga, T.: Functional roles of gangliosides in neurodevelopment: an overview of recent advances. Neurochem Res 37(6), 1230–1244 (2012). doi:10.1007/s11064-012-0744-y
Sonnino, S., Mauri, L., Chigorno, V., Prinetti, A.: Gangliosides as components of lipid membrane domains. Glycobiology 17(1), 1R–13R (2007). doi:10.1093/glycob/cwl052
Schengrund, C.L.: “Multivalent” saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochem Pharmacol 65(5), 699–707 (2003)
Schnaar, R.L.: Brain gangliosides in axon-myelin stability and axon regeneration. FEBS Lett 584(9), 1741–1747 (2010). doi:10.1016/j.febslet.2009.10.011
Yoon, S.J., Nakayama, K., Hikita, T., Handa, K., Hakomori, S.I.: Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci U S A 103(50), 18987–18991 (2006). doi:10.1073/pnas.0609281103
Inokuchi, J.: GM3 and diabetes. Glycoconj J 31(3), 193–197 (2014). doi:10.1007/s10719-013-9516-4
Lakshminarayan, R., Wunder, C., Becken, U., Howes, M.T., Benzing, C., Arumugam, S., Sales, S., Ariotti, N., Chambon, V., Lamaze, C., Loew, D., Shevchenko, A., Gaus, K., Parton, R.G., Johannes, L.: Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers. Nat Cell Biol 16(6), 595–606 (2014). doi:10.1038/ncb2970
Ichikawa, S., Ozawa, K., Hirabayashi, Y.: Molecular cloning and expression of mouse ceramide glucosyltransferase. Biochem Mol Biol Int 44(6), 1193–1202 (1998)
Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K.I., Hirabayashi, Y.: Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc Natl Acad Sci U S A 93(10), 4638–4643 (1996)
Yamashita, T., Wada, R., Proia, R.L.: Early developmental expression of the gene encoding glucosylceramide synthase, the enzyme controlling the first committed step of glycosphingolipid synthesis. Biochim Biophys Acta 1573(3), 236–240 (2002)
Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., Proia, R.L.: A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci U S A 96(16), 9142–9147 (1999)
Kolter, T.: A view on sphingolipids and disease. Chem Phys Lipids 164(6), 590–606 (2011). doi:10.1016/j.chemphyslip.2011.04.013
Yamashita, T., Allende, M.L., Kalkofen, D.N., Werth, N., Sandhoff, K., Proia, R.L.: Conditional LoxP-flanked glucosylceramide synthase allele controlling glycosphingolipid synthesis. Genesis 43(4), 175–180 (2005). doi:10.1002/gene.20167
Jennemann, R., Sandhoff, R., Wang, S., Kiss, E., Gretz, N., Zuliani, C., Martin-Villalba, A., Jager, R., Schorle, H., Kenzelmann, M., Bonrouhi, M., Wiegandt, H., Grone, H.J.: Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth. Proc Natl Acad Sci U S A 102(35), 12459–12464 (2005). doi:10.1073/pnas.0500893102
Watanabe, S., Endo, S., Oshima, E., Hoshi, T., Higashi, H., Yamada, K., Tohyama, K., Yamashita, T., Hirabayashi, Y.: Glycosphingolipid synthesis in cerebellar Purkinje neurons: roles in myelin formation and axonal homeostasis. Glia 58(10), 1197–1207 (2010). doi:10.1002/glia.20999
Nordstrom, V., Willershauser, M., Herzer, S., Rozman, J., von Bohlen Und Halbach, O., Meldner, S., Rothermel, U., Kaden, S., Roth, F.C., Waldeck, C., Gretz, N., de Angelis, M.H., Draguhn, A., Klingenspor, M., Grone, H.J., Jennemann, R.: Neuronal expression of glucosylceramide synthase in central nervous system regulates body weight and energy homeostasis. PLoS Biol 11(3), e1001506 (2013)
Saadat, L., Dupree, J.L., Kilkus, J., Han, X., Traka, M., Proia, R.L., Dawson, G., Popko, B.: Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice. Glia 58(4), 391–398 (2010). doi:10.1002/glia.20930
Holleran, W.M., Takagi, Y., Uchida, Y.: Epidermal sphingolipids: metabolism, function, and roles in skin disorders. FEBS Lett 580(23), 5456–5466 (2006). doi:10.1016/j.febslet.2006.08.039
Rabionet, M., Gorgas, K., Sandhoff, R.: Ceramide synthesis in the epidermis. Biochim Biophys Acta 1841(3), 422–434 (2014). doi:10.1016/j.bbalip.2013.08.011
Jennemann, R., Sandhoff, R., Langbein, L., Kaden, S., Rothermel, U., Gallala, H., Sandhoff, K., Wiegandt, H., Grone, H.J.: Integrity and barrier function of the epidermis critically depend on glucosylceramide synthesis. J Biol Chem 282(5), 3083–3094 (2007). doi:10.1074/jbc.M610304200
Amen, N., Mathow, D., Rabionet, M., Sandhoff, R., Langbein, L., Gretz, N., Jackel, C., Grone, H.J., Jennemann, R.: Differentiation of epidermal keratinocytes is dependent on glucosylceramide:ceramide processing. Hum Mol Genet 22(20), 4164–4179 (2013). doi:10.1093/hmg/ddt264
Li, Z., Li, Y., Chakraborty, M., Fan, Y., Bui, H.H., Peake, D.A., Kuo, M.S., Xiao, X., Cao, G., Jiang, X.C.: Liver-specific deficiency of serine palmitoyltransferase subunit 2 decreases plasma sphingomyelin and increases apolipoprotein E levels. J Biol Chem 284(39), 27010–27019 (2009). doi:10.1074/jbc.M109.042028
Jennemann, R., Rothermel, U., Wang, S., Sandhoff, R., Kaden, S., Out, R., van Berkel, T.J., Aerts, J.M., Ghauharali, K., Sticht, C., Grone, H.J.: Hepatic glycosphingolipid deficiency and liver function in mice. Hepatology 51(5), 1799–1809 (2010). doi:10.1002/hep.23545
Jennemann, R., Kaden, S., Sandhoff, R., Nordstrom, V., Wang, S., Volz, M., Robine, S., Amen, N., Rothermel, U., Wiegandt, H., Grone, H.J.: Glycosphingolipids are essential for intestinal endocytic function. J Biol Chem 287(39), 32598–32616 (2012). doi:10.1074/jbc.M112.371005
Nishie, T., Hikimochi, Y., Zama, K., Fukusumi, Y., Ito, M., Yokoyama, H., Naruse, C., Asano, M.: Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology 20(10), 1311–1322 (2010). doi:10.1093/glycob/cwq098
Kumagai, T., Tanaka, M., Yokoyama, M., Sato, T., Shinkai, T., Furukawa, K.: Early lethality of beta-1,4-galactosyltransferase V-mutant mice by growth retardation. Biochem Biophys Res Commun 379(2), 456–459 (2009). doi:10.1016/j.bbrc.2008.12.078
Lutz, M.S., Jaskiewicz, E., Darling, D.S., Furukawa, K., Young Jr., W.W.: Cloned beta 1,4 N-acetylgalactosaminyltransferase synthesizes GA2 as well as gangliosides GM2 and GD2. GM3 synthesis has priority over GA2 synthesis for utilization of lactosylceramide substrate in vivo. J Biol Chem 269(46), 29227–29231 (1994)
Takamiya, K., Yamamoto, A., Furukawa, K., Yamashiro, S., Shin, M., Okada, M., Fukumoto, S., Haraguchi, M., Takeda, N., Fujimura, K., Sakae, M., Kishikawa, M., Shiku, H., Aizawa, S.: Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci U S A 93(20), 10662–10667 (1996)
Sheikh, K.A., Sun, J., Liu, Y., Kawai, H., Crawford, T.O., Proia, R.L., Griffin, J.W., Schnaar, R.L.: Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A 96(13), 7532–7537 (1999)
Chiavegatto, S., Sun, J., Nelson, R.J., Schnaar, R.L.: A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp Neurol 166(2), 227–234 (2000). doi:10.1006/exnr.2000.7504
Yin, X., Crawford, T.O., Griffin, J.W., Tu, P., Lee, V.M., Li, C., Roder, J., Trapp, B.D.: Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci Off J Soc Neurosci 18(6), 1953–1962 (1998)
Sha, S., Zhou, L., Yin, J., Takamiya, K., Furukawa, K., Sokabe, M., Chen, L.: Deficits in cognitive function and hippocampal plasticity in GM2/GD2 synthase knockout mice. Hippocampus 24(4), 369–382 (2014)
Takamiya, K., Yamamoto, A., Furukawa, K., Zhao, J., Fukumoto, S., Yamashiro, S., Okada, M., Haraguchi, M., Shin, M., Kishikawa, M., Shiku, H., Aizawa, S.: Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone. Proc Natl Acad Sci U S A 95(21), 12147–12152 (1998)
Sandhoff, R., Geyer, R., Jennemann, R., Paret, C., Kiss, E., Yamashita, T., Gorgas, K., Sijmonsma, T.P., Iwamori, M., Finaz, C., Proia, R.L., Wiegandt, H., Grone, H.J.: Novel class of glycosphingolipids involved in male fertility. J Biol Chem 280(29), 27310–27318 (2005). doi:10.1074/jbc.M502775200
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J.L., Werth, N., Sandhoff, R., Sandhoff, K., Proia, R.L.: Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci U S A 100(6), 3445–3449 (2003). doi:10.1073/pnas.0635898100
Wang, X.Q., Lee, S., Wilson, H., Seeger, M., Iordanov, H., Gatla, N., Whittington, A., Bach, D., Lu, J.Y., Paller, A.S.: Ganglioside GM3 depletion reverses impaired wound healing in diabetic mice by activating IGF-1 and insulin receptors. J Invest Dermatol 134(5), 1446–1455 (2014). doi:10.1038/jid.2013.532
Yoshikawa, M., Go, S., Takasaki, K., Kakazu, Y., Ohashi, M., Nagafuku, M., Kabayama, K., Sekimoto, J., Suzuki, S., Takaiwa, K., Kimitsuki, T., Matsumoto, N., Komune, S., Kamei, D., Saito, M., Fujiwara, M., Iwasaki, K., Inokuchi, J.: Mice lacking ganglioside GM3 synthase exhibit complete hearing loss due to selective degeneration of the organ of Corti. Proc Natl Acad Sci U S A 106(23), 9483–9488 (2009). doi:10.1073/pnas.0903279106
Okada, M., Itoh Mi, M., Haraguchi, M., Okajima, T., Inoue, M., Oishi, H., Matsuda, Y., Iwamoto, T., Kawano, T., Fukumoto, S., Miyazaki, H., Furukawa, K., Aizawa, S.: b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J Biol Chem 277(3), 1633–1636 (2002). doi:10.1074/jbc.C100395200
Kawai, H., Allende, M.L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J.N., Werth, N., Bierfreund, U., Sandhoff, K., Proia, R.L.: Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J Biol Chem 276(10), 6885–6888 (2001). doi:10.1074/jbc.C000847200
Handa, Y., Ozaki, N., Honda, T., Furukawa, K., Tomita, Y., Inoue, M., Okada, M., Sugiura, Y.: GD3 synthase gene knockout mice exhibit thermal hyperalgesia and mechanical allodynia but decreased response to formalin-induced prolonged noxious stimulation. Pain 117(3), 271–279 (2005). doi:10.1016/j.pain.2005.06.016
Tajima, O., Egashira, N., Ohmi, Y., Fukue, Y., Mishima, K., Iwasaki, K., Fujiwara, M., Inokuchi, J., Sugiura, Y., Furukawa, K.: Reduced motor and sensory functions and emotional response in GM3-only mice: emergence from early stage of life and exacerbation with aging. Behav Brain Res 198(1), 74–82 (2009). doi:10.1016/j.bbr.2008.10.024
Inoue, M., Fujii, Y., Furukawa, K., Okada, M., Okumura, K., Hayakawa, T., Sugiura, Y.: Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J Biol Chem 277(33), 29881–29888 (2002). doi:10.1074/jbc.M201631200
Yamashita, T., Wu, Y.P., Sandhoff, R., Werth, N., Mizukami, H., Ellis, J.M., Dupree, J.L., Geyer, R., Sandhoff, K., Proia, R.L.: Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. Proc Natl Acad Sci U S A 102(8), 2725–2730 (2005). doi:10.1073/pnas.0407785102
Okuda, T., Tokuda, N., Numata, S., Ito, M., Ohta, M., Kawamura, K., Wiels, J., Urano, T., Tajima, O., Furukawa, K.: Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem 281(15), 10230–10235 (2006). doi:10.1074/jbc.M600057200
Porubsky, S., Speak, A.O., Luckow, B., Cerundolo, V., Platt, F.M., Grone, H.J.: Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc Natl Acad Sci U S A 104(14), 5977–5982 (2007). doi:10.1073/pnas.0611139104
Zhou, D., Mattner, J., Cantu 3rd, C., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y., Hudspeth, K., Wu, Y.P., Yamashita, T., Teneberg, S., Wang, D., Proia, R.L., Levery, S.B., Savage, P.B., Teyton, L., Bendelac, A.: Lysosomal glycosphingolipid recognition by NKT cells. Science 306(5702), 1786–1789 (2004). doi:10.1126/science.1103440
Biellmann, F., Hulsmeier, A.J., Zhou, D., Cinelli, P., Hennet, T.: The Lc3-synthase gene B3gnt5 is essential to pre-implantation development of the murine embryo. BMC Dev Biol 8, 109 (2008). doi:10.1186/1471-213X-8-109
Togayachi, A., Kozono, Y., Ikehara, Y., Ito, H., Suzuki, N., Tsunoda, Y., Abe, S., Sato, T., Nakamura, K., Suzuki, M., Goda, H.M., Ito, M., Kudo, T., Takahashi, S., Narimatsu, H.: Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation. Proc Natl Acad Sci U S A 107(26), 11900–11905 (2010). doi:10.1073/pnas.0914298107
Kuan, C.T., Chang, J., Mansson, J.E., Li, J., Pegram, C., Fredman, P., McLendon, R.E., Bigner, D.D.: Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase–a key enzyme in lacto-neolacto ganglioside synthesis. BMC Dev Biol 10, 114 (2010). doi:10.1186/1471-213X-10-114
Schulte, S., Stoffel, W.: Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning, and expression. Proc Natl Acad Sci U S A 90(21), 10265–10269 (1993)
Coetzee, T., Fujita, N., Dupree, J., Shi, R., Blight, A., Suzuki, K., Popko, B.: Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86(2), 209–219 (1996)
Bosio, A., Binczek, E., Stoffel, W.: Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci U S A 93(23), 13280–13285 (1996)
Zoller, I., Bussow, H., Gieselmann, V., Eckhardt, M.: Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level. Glia 52(3), 190–198 (2005). doi:10.1002/glia.20230
Hirahara, Y., Tsuda, M., Wada, Y., Honke, K.: cDNA cloning, genomic cloning, and tissue-specific regulation of mouse cerebroside sulfotransferase. Eur J Biochem FEBS 267(7), 1909–1917 (2000)
Eckhardt, M.: The role and metabolism of sulfatide in the nervous system. Mol Neurobiol 37(2–3), 93–103 (2008). doi:10.1007/s12035-008-8022-3
Takahashi, T., Suzuki, T.: Role of sulfatide in normal and pathological cells and tissues. J Lipid Res 53(8), 1437–1450 (2012). doi:10.1194/jlr.R026682
Ishizuka, I.: Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 36(4), 245–319 (1997)
Honke, K., Hirahara, Y., Dupree, J., Suzuki, K., Popko, B., Fukushima, K., Fukushima, J., Nagasawa, T., Yoshida, N., Wada, Y., Taniguchi, N.: Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci U S A 99(7), 4227–4232 (2002). doi:10.1073/pnas.032068299
Hoshi, T., Suzuki, A., Hayashi, S., Tohyama, K., Hayashi, A., Yamaguchi, Y., Takeuchi, K., Baba, H.: Nodal protrusions, increased Schmidt-Lanterman incisures, and paranodal disorganization are characteristic features of sulfatide-deficient peripheral nerves. Glia 55(6), 584–594 (2007). doi:10.1002/glia.20487
Ishibashi, T., Dupree, J.L., Ikenaka, K., Hirahara, Y., Honke, K., Peles, E., Popko, B., Suzuki, K., Nishino, H., Baba, H.: A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci Off J Soc Neurosci 22(15), 6507–6514 (2002)
Hayashi, A., Kaneko, N., Tomihira, C., Baba, H.: Sulfatide decrease in myelin influences formation of the paranodal axo-glial junction and conduction velocity in the sciatic nerve. Glia 61(4), 466–474 (2013). doi:10.1002/glia.22447
Lullmann-Rauch, R., Matzner, U., Franken, S., Hartmann, D., Gieselmann, V.: Lysosomal sulfoglycolipid storage in the kidneys of mice deficient for arylsulfatase A (ASA) and of double-knockout mice deficient for ASA and galactosylceramide synthase. Histochem Cell Biol 116(2), 161–169 (2001). doi:10.1007/s004180100286
Sandhoff, R., Hepbildikler, S.T., Jennemann, R., Geyer, R., Gieselmann, V., Proia, R.L., Wiegandt, H., Grone, H.J.: Kidney sulfatides in mouse models of inherited glycosphingolipid disorders: determination by nano-electrospray ionization tandem mass spectrometry. J Biol Chem 277(23), 20386–20398 (2002). doi:10.1074/jbc.M110641200
Stettner, P., Bourgeois, S., Marsching, C., Traykova-Brauch, M., Porubsky, S., Nordstrom, V., Hopf, C., Koesters, R., Sandhoff, R., Wiegandt, H., Wagner, C.A., Grone, H.J., Jennemann, R.: Sulfatides are required for renal adaptation to chronic metabolic acidosis. Proc Natl Acad Sci U S A 110(24), 9998–10003 (2013). doi:10.1073/pnas.1217775110
Schulze, H., Sandhoff, K.: Sphingolipids and lysosomal pathologies. Biochim Biophys Acta 1841(5), 799–810 (2014). doi:10.1016/j.bbalip.2013.10.015
Farukhi, F., Dakkouri, C., Wang, H., Wiztnitzer, M., Traboulsi, E.I.: Etiology of vision loss in ganglioside GM3 synthase deficiency. Ophthalmic Genet 27(3), 89–91 (2006). doi:10.1080/13816810600862626
Wang, H., Bright, A., Xin, B., Bockoven, J.R., Paller, A.S.: Cutaneous dyspigmentation in patients with ganglioside GM3 synthase deficiency. Am J Med Genet A 161A(4), 875–879 (2013). doi:10.1002/ajmg.a.35826
Simpson, M.A., Cross, H., Proukakis, C., Priestman, D.A., Neville, D.C., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M.A., Dwek, R.A., Butters, T.D., Platt, F.M., Crosby, A.H.: Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36(11), 1225–1229 (2004). doi:10.1038/ng1460
Harlalka, G.V., Lehman, A., Chioza, B., Baple, E.L., Maroofian, R., Cross, H., Sreekantan-Nair, A., Priestman, D.A., Al-Turki, S., McEntagart, M.E., Proukakis, C., Royle, L., Kozak, R.P., Bastaki, L., Patton, M., Wagner, K., Coblentz, R., Price, J., Mezei, M., Schlade-Bartusiak, K., Platt, F.M., Hurles, M.E., Crosby, A.H.: Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis. Brain J Neurol 136(Pt 12), 3618–3624 (2013). doi:10.1093/brain/awt270
Natoli, T.A., Husson, H., Rogers, K.A., Smith, L.A., Wang, B., Budman, Y., Bukanov, N.O., Ledbetter, S.R., Klinger, K.W., Leonard, J.P., Ibraghimov-Beskrovnaya, O.: Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease. Hum Mol Genet 21(15), 3397–3407 (2012). doi:10.1093/hmg/dds172
Natoli, T.A., Smith, L.A., Rogers, K.A., Wang, B., Komarnitsky, S., Budman, Y., Belenky, A., Bukanov, N.O., Dackowski, W.R., Husson, H., Russo, R.J., Shayman, J.A., Ledbetter, S.R., Leonard, J.P., Ibraghimov-Beskrovnaya, O.: Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat Med 16(7), 788–792 (2010). doi:10.1038/nm.2171
McDonald, G., Deepak, S., Miguel, L., Hall, C.J., Isenberg, D.A., Magee, A.I., Butters, T., Jury, E.C.: Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients. J Clin Invest 124(2), 712–724 (2014). doi:10.1172/JCI69571
Acknowledgments
This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Conflict of interest
The authors declare that they are free from conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Allende, M.L., Proia, R.L. Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function. Glycoconj J 31, 613–622 (2014). https://doi.org/10.1007/s10719-014-9563-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-014-9563-5